SCHEMBL6312866

SCHEMBL6312866

CCCC[Sn](CCCC)(CCCC)C1=CC(N2C(=O)c3ccccc3C2=O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.38
GRM5 P41594 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
DDB1 Q16531 3/20 0.36
CRBN Q96SW2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
CHRM2 P08172 1/20 0.36
OPRM1 P35372 1/20 0.36
IKZF3 Q9UKT9 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ASAH1 Q13510 1/20 0.36
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
DRD2 P14416 1/20 0.33
SLC6A4 P31645 1/20 0.33
ALDH2 P05091 1/20 0.33
ALDH3A1 P30838 1/20 0.33
CES1 P23141 2/20 0.32
CDC25A P30304 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10413063 0.79 CYP1A2 (0.43) CYP1A2GRM5L3MBTL1DDB1CRBN
SCHEMBL16544594 0.71 CYP1A2 (0.46) CYP1A2GRM5L3MBTL1DDB1CRBN
SCHEMBL15540729 0.67 CYP1A2 (0.51) CYP1A2GRM5L3MBTL1DDB1CRBN
SCHEMBL6311512 0.67
SCHEMBL16422618 0.63 TSHR (0.43) CYP1A2GRM5L3MBTL1DDB1CRBN
SCHEMBL6788210 0.62 NR1H2 (0.43) CYP1A2ALDH1A1TSHRNR1H2NR1H3
SCHEMBL3300786 0.62 TLR4 (0.32) TSHR
SCHEMBL16422434 0.61 CYP1A2 (0.38) CYP1A2GRM5DDB1CRBNALDH1A1
SCHEMBL20337367 0.61 L3MBTL1 (0.53) L3MBTL1ALDH1A1TSHRTDP1ASAH1
SCHEMBL15510834 0.60 DRD3 (0.45) ALDH1A1TSHRALDH2ALDH3A1CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed
US-4945160-A Preparation of certain 7-substituted quinolones WARNER-LAMBERT COMPANY (US) 1990-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 CYP1A2 822/4885GRM5 3950/4885L3MBTL1 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.